Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.
Pitocco
D
D
Universit à Cattolica, Rome, Italy.
DiStasio
E
E
Crinò
A
A
Manfrini
S
S
Guglielmi
C
C
Visalli
N
N
Suraci
C
C
Matteoli
M C
MC
Cavallo
M G
MG
Bizzarri
C
C
Pozzilli
P
P
D017668:Age of Onset; D000375:Aging / Q000502:physiology*; D002096:C-Peptide / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D050417:Insulin-Secreting Cells / Q000378:metabolism*; D008297:Male
D002096:C-Peptide; D007155:Immunologic Factors